Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

NCT00205075 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2015-12-09

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.

Conditions

  • Hepatic Fibrogenesis
  • Hepatitis C

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Adnan Said, MD · University of Wisconsin, Madison

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00205075 on ClinicalTrials.gov